Connect with us
mm

Michel van Harten M.D., CEO of myTomorrows

ืžื™ื›ืœ ื•ืืŸ ื”ืืจื˜ืŸ, MD, ื”ื•ื ื”ืžื ื›"ืœ ื”ื—ื–ื•ื ื™ ื‘ืจืืฉ myTomorrows, ื—ื‘ืจืช ื˜ื›ื ื•ืœื•ื’ื™ื” ืจืคื•ืื™ืช ืฉืคื™ืชื—ื” ืคืœื˜ืคื•ืจืžืช AI ื“ื•ืจ ื”ื‘ื ืœืฆื•ืจืš ื”ื’ื‘ืจืช ื”ื”ืจืฉืžื” ืœื ื™ืกื•ื™ื™ื ืงืœื™ื ื™ื™ื, ื•ื‘ื›ืš ืžืคืจืงืช ืžื—ืกื•ืžื™ื ืขื‘ื•ืจ ื—ื•ืœื™ื ื”ืžื—ืคืฉื™ื ืืคืฉืจื•ื™ื•ืช ื˜ื™ืคื•ืœ. ื˜ื›ื ื•ืœื•ื’ื™ื” ื™ื™ื—ื•ื“ื™ืช ื•ื‘ืขืœื•ืช ื–ื›ื™ื™ื ื•ืช ืžื‘ืฆืขืช ื—ื™ืคื•ืฉ ืžืงื™ืฃ ื•ืžื“ื•ื™ืง ืฉืœ ื ื™ืกื•ื™ื™ื ืงืœื™ื ื™ื™ื ืžืจืฉื™ืžื•ืช ืฆื™ื‘ื•ืจื™ื•ืช ื’ืœื•ื‘ืœื™ื•ืช, ื•ืžื—ื‘ืจืช ื‘ื™ืขื™ืœื•ืช ื—ื•ืœื™ื, ืจื•ืคืื™ื, ืืชืจื™ ื ื™ืกื•ื™ื™ื ื•- BioPharma ื›ื“ื™ ืœืคืฉื˜ ื•ืœืื™ืฅ ืืช ื”ื’ื™ืฉื” ืœืชืจื•ืคื•ืช ื‘ืคื™ืชื•ื—.

ืžื™ื›ืœ ืจื›ืฉ ืืช ื”ืชื•ืืจ BSc ื‘ื›ืœื›ืœื” ื•ืืช ื”ืชื•ืืจ ื”ืจืคื•ืื™ ืฉืœื• ื‘ืื•ื ื™ื‘ืจืกื™ื˜ืช ืืžืกื˜ืจื“ื. ื”ื•ื ืขื‘ื“ ื›ืจื•ืคื ื‘ื‘ื™ืช ื”ื—ื•ืœื™ื ืื ื˜ื•ื ื™ ื•ืืŸ ืœื™ื•ื•ื ื”ื•ืง, ื‘ื™ืช ื—ื•ืœื™ื ืžื•ืžื—ื” ื•ืžื›ื•ืŸ ืžื—ืงืจ ืœืกืจื˜ืŸ, ื‘ืžื—ืœืงื” ืœืื•ื ืงื•ืœื•ื’ื™ื” ื›ื™ืจื•ืจื’ื™ืช. ื›ืจื•ืคื, ืขื ื™ื•ืชืจ ืž-15 ืฉื ื•ืช ื ื™ืกื™ื•ืŸ ื‘ืชืขืฉื™ื™ืช ื”ื‘ืจื™ืื•ืช ื•ื”ืคืืจืžื”, ืžื™ื›ืœ ืžื—ื–ื™ืง ื‘ื”ื‘ื ื” ืขืžื•ืงื” ืฉืœ ื”ืืชื’ืจื™ื ืฉื—ื•ืœื™ื ื•ื ื•ืชื ื™ ืฉื™ืจื•ืชื™ ื‘ืจื™ืื•ืช ืคื ื™ื ืืœื™ื”ื.
More Posts